» Articles » PMID: 34832638

As a Good Model to Study Pathogenesis

Overview
Journal Pathogens
Date 2021 Nov 27
PMID 34832638
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The invertebrate model, , has been widely used to study host-pathogen interactions due to its cheapness, ease of handling, and similar mammalian innate immune system. larvae have been proven to be useful and a reliable model for analyzing pathogenesis mechanisms of multidrug resistant an opportunistic pathogen difficult to kill. This review describes the detailed experimental design of / models, and provides a comprehensive comparison of various virulence factors and therapy strategies using the host. These investigations highlight the importance of this host-pathogen model for in vivo pathogen virulence studies. On the long term, further development of the / model will offer promising insights for clinical treatments of infection.

Citing Articles

Comparison of the virulence of community- and hospital- isolated Acinetobacter baumannii in HeLa cell line and insect model, Galleria mellonella.

Muzahid N, Ramesh A, Siew T, Hasan M, Narayanan K, Rahman S Access Microbiol. 2025; 7(2).

PMID: 39959467 PMC: 11829074. DOI: 10.1099/acmi.0.000858.v3.


(Greater Wax Moth) as a Reliable Animal Model to Study the Efficacy of Nanomaterials in Fighting Pathogens.

Villani S, Calcagnile M, Demitri C, Alifano P Nanomaterials (Basel). 2025; 15(1.

PMID: 39791825 PMC: 11723170. DOI: 10.3390/nano15010067.


Resistance to bacteriophage incurs a cost to virulence in drug-resistant .

Manley R, Fitch C, Francis V, Temperton I, Turner D, Fletcher J J Med Microbiol. 2024; 73(5).

PMID: 38743467 PMC: 11170128. DOI: 10.1099/jmm.0.001829.


Characterization and efficacy against carbapenem-resistant of a novel phage from sewage.

Wang Z, Yang X, Wang H, Wang S, Fang R, Li X Front Cell Infect Microbiol. 2024; 14:1382145.

PMID: 38736748 PMC: 11086170. DOI: 10.3389/fcimb.2024.1382145.


larvae as a novel model for the study of virulence and antimicrobial resistance.

Rakovitsky N, Temkin E, Hameir A, Lurie-Weinberger M, Keren-Paz A, Carmeli Y Front Microbiol. 2024; 15:1375787.

PMID: 38476953 PMC: 10927975. DOI: 10.3389/fmicb.2024.1375787.


References
1.
Morris F, Dexter C, Kostoulias X, Uddin M, Peleg A . The Mechanisms of Disease Caused by . Front Microbiol. 2019; 10:1601. PMC: 6650576. DOI: 10.3389/fmicb.2019.01601. View

2.
Cruz-Muniz M, Lopez-Jacome L, Hernandez-Duran M, Franco-Cendejas R, Licona-Limon P, Ramos-Balderas J . Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections. Int J Antimicrob Agents. 2016; 49(1):88-92. DOI: 10.1016/j.ijantimicag.2016.08.022. View

3.
Jeon J, Park J, Yong D . Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia. BMC Microbiol. 2019; 19(1):70. PMC: 6444642. DOI: 10.1186/s12866-019-1443-5. View

4.
Gebhardt M, Gallagher L, Jacobson R, Usacheva E, Peterson L, Zurawski D . Joint Transcriptional Control of Virulence and Resistance to Antibiotic and Environmental Stress in Acinetobacter baumannii. mBio. 2015; 6(6):e01660-15. PMC: 4659468. DOI: 10.1128/mBio.01660-15. View

5.
Spicer P, Shah S, Henslee A, Watson B, Kinard L, Kretlow J . Evaluation of antibiotic releasing porous polymethylmethacrylate space maintainers in an infected composite tissue defect model. Acta Biomater. 2013; 9(11):8832-9. DOI: 10.1016/j.actbio.2013.07.018. View